Literature DB >> 33044495

Diabetes Distress Among Dyads of Patients and Their Health Supporters: Links With Functional Support, Metabolic Outcomes, and Cardiac Risk.

Aaron A Lee1, Michele Heisler2,3,4, Ranak Trivedi5,6, D Scott Obrosky7,8, Maria K Mor7, John D Piette2,3, Ann-Marie Rosland7,8.   

Abstract

BACKGROUND: Patients with diabetes (PWD) often experience diabetes distress which is associated with worse self-management and glycemic control. In contrast, PWD who receive support from family and friends (supporters) have better diabetes outcomes.
PURPOSE: To examine the associations of PWD diabetes distress and supporters' distress about PWDs' diabetes with supporters' roles and PWD cardiometabolic outcomes.
METHODS: We used baseline data from 239 adults with Type 2 diabetes and their supporters participating in a longitudinal trial. PWD and supporter diabetes distress (high vs. low) were determined using the Problem Areas in Diabetes Scale-5. Outcomes included PWD-reported help from supporters with self-care activities, supporter-reported strain, PWD metabolic outcomes (glycemic control [HbA1c], systolic blood pressure [SBP], and non-HDL cholesterol) and 5 and 10 year risk of cardiac event (calculated using the United Kingdom Prospective Diabetes Study algorithm).
RESULTS: PWDs with high diabetes distress were more likely to report that their supporters helped with taking medications, coordinating medical care, and home glucose testing (p's < .05), but not more likely to report help with diet or exercise. High supporter distress was associated with greater supporter strain (p < .001). High supporter diabetes distress was associated with higher PWD HbA1c (p = .045), non-HDL cholesterol (p = .011), and 5 (p = .002) and 10 year (p = .001) cardiac risk.
CONCLUSIONS: Adults with high diabetes distress report more supporter help with medically focused self-management but not with diet and exercise. Supporter distress about PWD diabetes was consistently associated with worse outcomes. PWD diabetes distress had mixed associations with their diabetes outcomes. © Society of Behavioral Medicine 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac risk; Diabetes distress; Hemoglobin A1c; Informal support persons; Systolic blood pressure; Type 2 diabetes

Mesh:

Substances:

Year:  2021        PMID: 33044495      PMCID: PMC8677591          DOI: 10.1093/abm/kaaa081

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  25 in total

1.  Family members' experiences supporting adults with chronic illness: A national survey.

Authors:  Aaron A Lee; John D Piette; Michele Heisler; Mary R Janevic; Kenneth M Langa; Ann-Marie Rosland
Journal:  Fam Syst Health       Date:  2017-12       Impact factor: 1.950

2.  The associations between diabetes distress and self-efficacy, medication adherence, self-care activities and disease control depend on the way diabetes distress is measured: Comparing the DDS-17, DDS-2 and the PAID-5.

Authors:  Boon-How Chew; Rimke C Vos; Frans Pouwer; Guy E H M Rutten
Journal:  Diabetes Res Clin Pract       Date:  2018-05-24       Impact factor: 5.602

3.  Family influences on self-management among functionally independent adults with diabetes or heart failure: do family members hinder as much as they help?

Authors:  Ann-Marie Rosland; Michele Heisler; Hwa-Jung Choi; Maria J Silveira; John D Piette
Journal:  Chronic Illn       Date:  2010-03

4.  Depressive symptoms, serious psychological distress, diabetes distress and cardiovascular risk factor control in patients with type 2 diabetes.

Authors:  Rhonda J Winchester; Joni S Williams; Tamara E Wolfman; Leonard E Egede
Journal:  J Diabetes Complications       Date:  2015-11-14       Impact factor: 2.852

5.  The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes.

Authors:  Lawrence Fisher; Russell E Glasgow; Lisa A Strycker
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 19.112

Review 6.  Family interventions to improve diabetes outcomes for adults.

Authors:  Arshiya A Baig; Amanda Benitez; Michael T Quinn; Deborah L Burnet
Journal:  Ann N Y Acad Sci       Date:  2015-08-06       Impact factor: 5.691

7.  Predicting diabetes distress in patients with Type 2 diabetes: a longitudinal study.

Authors:  L Fisher; J T Mullan; M M Skaff; R E Glasgow; P Arean; D Hessler
Journal:  Diabet Med       Date:  2009-06       Impact factor: 4.359

8.  Family support, medication adherence, and glycemic control among adults with type 2 diabetes.

Authors:  Lindsay S Mayberry; Chandra Y Osborn
Journal:  Diabetes Care       Date:  2012-04-26       Impact factor: 19.112

9.  Reductions in regimen distress are associated with improved management and glycemic control over time.

Authors:  Danielle Hessler; Lawrence Fisher; Russell E Glasgow; Lisa A Strycker; L Miriam Dickinson; Patricia A Arean; Umesh Masharani
Journal:  Diabetes Care       Date:  2013-10-29       Impact factor: 19.112

10.  Engaging family supporters of adult patients with diabetes to improve clinical and patient-centered outcomes: study protocol for a randomized controlled trial.

Authors:  Ann-Marie Rosland; John D Piette; Ranak Trivedi; Eve A Kerr; Shelley Stoll; Adam Tremblay; Michele Heisler
Journal:  Trials       Date:  2018-07-24       Impact factor: 2.279

View more
  2 in total

1.  The influence of emotion regulation and family involvement on diabetes distress among adults with type 2 diabetes.

Authors:  Patric J Leukel; Sophie R Kollin; Bianca R Lewis; Aaron A Lee
Journal:  J Behav Med       Date:  2022-08-10

2.  Comparing the effectiveness of Family Support for Health Action (FAM-ACT) with traditional community health worker-led interventions to improve adult diabetes management and outcomes: study protocol for a randomized controlled trial.

Authors:  Denise J Deverts; Michele Heisler; Edith C Kieffer; Gretchen A Piatt; Felix Valbuena; Jonathan G Yabes; Claudia Guajardo; Deliana Ilarraza-Montalvo; Gloria Palmisano; Glory Koerbel; Ann-Marie Rosland
Journal:  Trials       Date:  2022-10-03       Impact factor: 2.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.